← All patents

US20150239876A1

Salts of heterocyclic modulators of hif activity for treatment of disease

University of Texas System

Abstract

The present disclosure relates to salts of heterocyclic compounds and methods that inhibit HIF pathway activity. The compounds are designed to treat or prevent cancer and other hypoxia-mediated diseases.

University
University of Texas System
Assignee
Board Of Regents, University Of Texas System
Inventor
Philip Jones
Priority date
February 25, 2014
Filing date
February 25, 2015
Publication date
August 27, 2015
Language
en
Metadata fetched
August 29, 2026 00:22